The Latest Cardiac and Vascular News
Funding, which will support clinical studies of Restore’s novel transcatheter device, was co-led by Pitango HealthTech and a global strategic partner, with continued investment from existing investors including Peregrine Ventures, another global strategic partner, and new investment from…
OR YEHUDA, Israel, March 7, 2023 /PRNewswire/ — Restore Medical Ltd, a privately held medical device company, has successfully completed enrollment of the First In Human clinical study with its CONTRABAND™ device. The world’s first and only Pulmonary Artery Banding (PAB) transcatheter implant is designed to treat heart failure with reduced ejection fraction (HFrEF) and […]
ContraBand™ technology helps restore the heart’s functionality and may significantly improve patients’ quality of life OR YEHUDA, Israel, Dec. 7, 2021 /PRNewswire/ — Restore Medical Ltd., a clinical-stage MedTech company developing cardiac implants for the treatment of congestive heart failure (CHF), today announced promising preliminary results of the First-in-Human clinical trial of ContraBand™, a breakthrough treatment […]
